Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mutational analysis of KRAS and its clinical implications in cervical cancer patients.

Journal of gynecologic oncology - 1 Jan 2018

Jiang Wei, Xiang Libing, Pei Xuan, He Tiancong, Shen Xuxia, Wu Xiaohua, Yang Huijuan

Abstract excerpt

OBJECTIVE: The predictive and prognostic role of KRAS mutations in cervical cancer remains inconclusive. The aim of this study was to explore the clinicopathological and prognostic relevance of KRAS mutations in invasive cervical cancers (ICC). METHODS: Reverse transcription polymerase chain reaction (PCR) and Sanger sequencing were employed to detect KRAS mutations in 876 ICC patients. Quantitative real-time PCR...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Carcinoma, Adenosquamous

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Papillomavirus Infections

Share to Prognosis

Share to Proto-Oncogene Proteins p21(ras)

Share to Survival Analysis

Share to Treatment Outcome

Share to Uterine Cervical Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 29185262
DOI: 10.3802/jgo.2018.29.e4
PMCID: PMC5709530

Genes

KRAS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mutational analysis of KRAS and its clinical implications in cervical cancer patients.PMID 29185262Read ↗

Oncogenic impact of PIK3CA, KRAS, and PTEN mutations in cervical cancer among South Indian women.Semantic proximity Read ↗

KRAS Mutations in Squamous Cell Carcinomas of the LungSemantic proximity Read ↗

Oncogenic mutations in cervical cancer: genomic differences between adenocarcinomas and squamous cell carcinomas of the cervix.Semantic proximity Read ↗

Precise Classification of Cervical Carcinomas Combined with Somatic Mutation Profiling Contributes to Predicting Disease Outcome.Semantic proximity Read ↗

No evidence of oncogenic KRAS mutations in squamous cell carcinomas of the anogenital tract and head and neck region independent of human papillomavirus and p16(INK4a) status.Semantic proximity Read ↗

Mutation Analysis of Radioresistant Early-Stage Cervical Cancer.Semantic proximity Read ↗

Clinicopathologic Significance of EGFR Mutation and HPV Infection in Sinonasal Squamous Cell Carcinoma.Semantic proximity Read ↗

KRAS, BRAF and PIK3CA status in squamous cell anal carcinoma (SCAC).Semantic proximity Read ↗

ERBB2 mutation: A promising target in non-squamous cervical cancer.Semantic proximity Read ↗

Inverse correlation between RASSF1A hypermethylation, KRAS and BRAF mutations in cervical adenocarcinoma.Semantic proximity Read ↗

Targeting KRAS in gynecological malignancies.Semantic proximity Read ↗

Mutation analysis of EGFR and its correlation with the HPV in Indian cervical cancer patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.